Skip to main content
Clinical Trials/NCT04954222
NCT04954222
Completed
Not Applicable

Tracking the Recovery of Respiratory Physiology in COVID-19 Patients a Pilot Study

Mayo Clinic2 sites in 1 country80 target enrollmentFebruary 14, 2022
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Mayo Clinic
Enrollment
80
Locations
2
Primary Endpoint
change in quality of life
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to determine the effects of the clinical course of treatment as well as long-term symptoms of COVID-19 on respiratory function, exercise capacity, and quality of life.

Detailed Description

This study will be completed over 4 sessions at the Mayo Clinic at either the Scottsdale Arizona or Rochester Minnesota locations. You will be asked to complete a series of questionnaires, lung function tests, and exercise tests at two time points: ≥ 28 days post diagnosis and 4-6 months after the first laboratory visit. All visits will take approximately 2 hours. During visits 1 and 3 a series of questionnaires as well as breathing tests, and an exercise test will be completed on a stationary bike. You will also be asked to breathe a gas mixture out of a bag to obtain measures of gas movement and sensitivity. During visits 2 and 4 you will complete an exercise test on a stationary bike to measure changes from the previous exercise test and a chest scan.

Registry
clinicaltrials.gov
Start Date
February 14, 2022
End Date
January 8, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Courtney M. Wheatley

Co-Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Have a documented positive qRT-PCR for SARS-CoV-2 confirming prior COVID-19 diagnosis
  • At least 18 years of age.
  • Female subjects must not be pregnant or trying to become pregnant during the duration of study participation.
  • No known plans to move out of the state, or become unable to return to one of the Mayo Clinic sites for follow-up testing.
  • Must be able to provide clear informed written consent.

Exclusion Criteria

  • Individuals with pacemakers or other implantable devices that will make interpreting a CT scan challenging.
  • Individuals with major limitations to exercise.

Outcomes

Primary Outcomes

change in quality of life

Time Frame: through study completion, an average of 5 months

SF-36 questionnaire assessment of physical and mental health. Two scores one for physical functioning and one for mental functioning. Scores range from 0-100 with a higher score indicating better health

Change in diffusion capacity of the lungs

Time Frame: through study completion, an average of 5 months

change in diffusing capacity of the lungs for carbon monoxide and its components

Presence of post-exertional malaise

Time Frame: through study completion, an average of 5 months

Evaluation of change in performance on maximal exercise test over two days to identify presence of post-exertional malaise

change basic spirometry

Time Frame: through study completion, an average of 5 months

Measurement of basic lung function using forced vital capacity (FVC), slow vital capacity (SVC), forced expiratory volume at one second (FEV1), maximal inspiratory pressure (MIPS), maximal expiratory pressure (MEPS), exhaled nitric oxide (ExNO), forced oscillation technique (FOT), overnight pulse oximetry

Change in symptoms

Time Frame: through study completion, an average of 5 months

St. George's respiratory Questionnaire scoring of pulmonary symptoms. Scores range from 0 to 100, with higher scores indicating more limitations.

Change in airway morphology

Time Frame: through study completion, an average of 5 months

CT assessment of airway diameter and thickness

Change in peak aerobic capacity

Time Frame: through study completion, an average of 5 months

Change in examine post exertional malaise

Study Sites (2)

Loading locations...

Similar Trials